ClinicalTrials.gg
CompletedNCT00959452Updated Dec 7, 2023

Follow up of Patients Treated With Cognitive Behavioural Therapy for Hypochondria From 1997 to 2007

An interventional study of Cognitive behavioural therapy in Hypochondriasis, sponsored by University of Bergen. Completed at 1 site in Norway. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-12-07.

Sponsored by University of Bergen · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
250
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Research has shown that cognitive behavioural therapy is effective in treating hypochondria. However, no studies have examined the long term effect. The investigators have followed 56 patients treated for hypochondria between 1997 and 2001 and the investigators are now doing a 10 year follow-up (Part I). In another part of the study (Part II) the investigators compare the effect of 16 sessions vs. 5 sessions, with a follow-up period of at least 2 years. The investigators hypothesis is that the initial 1 year improvement will be sustained and that 5 sessions will yield the same results as 16 sessions.

Read the detailed description

The follow-up includes a telephone interview by independent researcher and the patients fill in the following questionnaires:

Whiteley Index (measures health anxiety), VAS-scales for health anxiety, worrying about symptoms and body checking, SF-36 (health related quality of life), Giessen Subjective Complaints List, Spielberger Trait and State Anxiety Scale Beck Depression Inventory, Eysenck Personality Questionnaire, General Health Questionnaire (GHQ 28), Somatic Amplification Scale,

02

Conditions studied

  • Hypochondriasis

Keywords

  • Hypochondria
  • Cognitive behavioural therapy
  • Long term follow-up
  • Psychosomatics
  • Psychotherapy
03

In context

Lead sponsor

University of Bergen is the lead sponsor of 143 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Fulfilling ICD-10 criteria for hypochondriacal disorder

Exclusion criteria

Exclusion Criteria:

  • Unwillingness to participate
  • Substance abuse
  • Serious psychological (f.inst. psychosis, major depression) or somatic (f.inst. cancer) disease
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
250 participants (actual)

Study arms

  • Experimental
    Psychotherapy

    Behavioral: Cognitive behavioural therapy

Interventions

  • BehavioralCognitive behavioural therapy

    16 sessions vs 5 sessions of cognitive behavioural therapy

    Also known as: Cognitive therapy

06

What researchers measure

Primary outcomes

  1. Level of health anxiety

    Time frame: 10 years follow up

Secondary outcomes

  1. Health related quality of life

    Time frame: 10 years follow-up

07

Study locations

1 site
  • Haraldsplass Deaconal Hospital
    Bergen, 5009, Norway
08

References and documents

Publications

  • Veddegjaerde KE, Sivertsen B, Wilhelmsen I, Skogen JC. Confirmatory factor analysis and item response theory analysis of the Whiteley Index. Results from a large population based study in Norway. The Hordaland Health Study (HUSK). J Psychosom Res. 2014 Sep;77(3):213-8. doi: 10.1016/j.jpsychores.2014.06.011. Epub 2014 Jun 28. PubMed 25149031 ↗
  • Veddegjaerde KF, Sivertsen B, Skogen JC, Smith ORF, Wilhelmsen I. Long-term effect of cognitive-behavioural therapy in patients with Hypochondriacal Disorder. BJPsych Open. 2020 Apr 29;6(3):e42. doi: 10.1192/bjo.2020.22. PubMed 32345417 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 1997, a primary completion of Dec 2010 and a completion of Dec 2022. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 13, 2009
First posted
Aug 14, 2009
Start
Jan 1997
Primary completionActual
Dec 2010
CompletionActual
Dec 2022
Last update
Dec 7, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 7, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00959452
Responsible party
Ingvard Wilhelmsen (Professor emeritus, University of Bergen) — Principal investigator
First posted
Aug 14, 2009
Start date
Jan 1997
Primary completion
Dec 2010
Completion
Dec 2022
Last update
Dec 7, 2023

Study contacts

Ingvard Wilhelmsen, PhD
principal investigator · University of Bergen

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion